Pancreatic Cancer Research

ResearcherAsahikawa Medical UniversityActive in the last 2 years

Toshikatsu Okumura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1810-007X; OpenAlex author ID A5054072947. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 11

  1. Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-026-02382-9↗
  2. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA. Last author DOI 10.1097/mpa.0000000000002315↗
  3. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. Last author DOI 10.1007/s00535-021-01846-4↗
  4. Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model. Last author DOI 10.1016/j.pan.2021.03.002↗
  5. Long Non-Coding RNAs in Epithelial-Mesenchymal Transition of Pancreatic Cancer. Last author DOI 10.3389/fmolb.2021.717890↗
  6. Resection for pancreatic cancer metastases contributes to survival: A case report with sequential tumor genotype profiling during the long-term postoperative c… Last author DOI 10.1097/md.0000000000020564↗
  7. Genetic Tracing of Clonal Expansion and Progression of Pancreatic Ductal Adenocarcinoma: A Case Report and Multi-Region Sequencing Analysis. Last author DOI 10.3389/fonc.2020.00728↗
  8. Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. Last author DOI 10.3892/ijo.2020.5096↗
  9. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. Co-author DOI 10.1053/j.gastro.2018.10.029↗
  10. Genetic analysis of postoperative recurrence of pancreatic cancer potentially owing to needle tract seeding during EUS-FNB. Last author DOI 10.1055/a-1034-7700↗
  11. Utility of "liquid biopsy" using pancreatic juice for early detection of pancreatic cancer. Last author DOI 10.1055/a-0721-1747↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yusuke Mizukami · 10 shared papers, 2018–2026 · strength 1.17
  2. Mikihiro Fujiya · 8 shared papers, 2019–2026 · strength 1.03
  3. Hidemasa Kawabata · 7 shared papers, 2018–2026 · strength 0.85
  4. Tetsuhiro Okada · 7 shared papers, 2018–2026 · strength 0.77
  5. Kenji Takahashi · 4 shared papers, 2021–2026 · strength 0.66
  6. Hiroki Sato · 6 shared papers, 2018–2024 · strength 0.63
  7. Junpei Sasajima · 6 shared papers, 2018–2021 · strength 0.51
  8. Yohei Kitano · 2 shared papers, 2024–2026 · strength 0.39
  9. Kazuya Koyama · 2 shared papers, 2024–2026 · strength 0.39
  10. Yuko Omori · 4 shared papers, 2018–2020 · strength 0.30
  11. Hiroaki Konishi · 2 shared papers, 2020–2022 · strength 0.21
  12. Shinya Tanaka · 2 shared papers, 2019–2020 · strength 0.16
  13. Toru Furukawa · 2 shared papers, 2019–2020 · strength 0.16
  14. Andrew Scott Liss · 1 shared paper, 2022 · strength 0.11
  15. Akemi Kita · 1 shared paper, 2020 · strength 0.09
  16. Shion Tachibana · 1 shared paper, 2020 · strength 0.09
  17. Hiroshi Nishihara · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.